James L. Abbruzzese - Researcher Profile

Publications

2 shown

Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205

James N. Atkins , B. Mirtsching , Saul E. Rivkin +12 more

Purpose Patients with advanced pancreas cancer present with disease that is poorly responsive to conventional therapies. Preclinical and early clinical evidence has supported ta...

2010 Journal of Clinical Oncology 622 citations

Phase II evaluation of fluorouracil and recombinant α-2a-interferon in previously untreated patients with pancreatic adenocarcinoma

Richard Pazdur , Jaffer J. Ajani , James L. Abbruzzese +7 more

This regimen had significant toxicity and little evidence of therapeutic activity against advanced pancreatic carcinoma.

1992 Cancer 46 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 668
Institution: Memorial Sloan Kettering Cancer Center

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-9223-2965

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.